SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Sense4Baby Inc. announced it has received $4 million in funding from the West Health Investment Fund.
Prime Healthcare Services, which includes San Diego’s Alvarado Hospital and Paradise Valley Hospital, was named one of the top 15 health systems in America by research firm Truven Health Analytics.
San Diego-based medical device maker Aethlon Medical Inc. has received a $22.8 million government subcontract to collaborate with the Columbus, Ohio-based nonprofit research and development organization Battelle Memorial Institute.
BIOTECH: Massachusetts Firm Offers $76 Per Share
In a deal that outpaced analysts’ most generous estimates, Life Technologies Corp. will be acquired by Waltham, Mass.-based Thermo Fisher Scientific Inc. for a resounding $13.6 billion.
Come April 24, the Monarch School, San Diego’s school for homeless kids, is set to open its new 2.2 acre campus in Barrio Logan just south of Petco Park. The usual panoply of elected officials are scheduled to attend, including Mayor Bob Filner and county Supervisor Greg Cox.
A group of pharmaceutical heavy hitters recently convened in San Diego for the annual meeting of industry trade group PhRMA. The roster included National Institutes of Health Director Francis Collins, Eli Lilly and Co. CEO John C. Lechleiter, and California Lt. Gov. Gavin Newsom, among others.
INSURANCE: Policies Are An Attractive Job Benefit, But Can Be Complicated
Employers continue to explore long-term care insurance to pad their benefits packages, in large part to attract and retain key talent. This is because long-term care insurance can be a boon to employees who foresee caring for aging family members, or who want to protect their own assets as they age.
INSURANCE: Law’s Complexities, Uncertainties Need to Be Understood
Small business owners in San Diego County will need to brush up on federal health care reform regulations in order to take full advantage of new tax incentives and potentially lower insurance costs.
REAL ESTATE: Company Boosts Portfolio With New $640M Acquisition
Leaders of BioMed Realty Trust Inc. note that the company’s recently announced $640 million acquisition of a life-sciences property portfolio, currently held by Wexford Science & Technology LLC of Baltimore, underscores two key aspects of a growth strategy that has actually been in place for some time.
MEDICAL DEVICES: Firm’s Strategies Include Targeting Other Conditions
Mick Farrell, the new CEO of San Diego’s ResMed Inc., thinks the market is ripe for growth for his company’s devices that treat sleep-related breathing disorders. In an interview, he weighed in on the direction he plans to take the company, which was founded by his father, Peter Farrell, in 1989. Mick Farrell took the helm of ResMed on March 1.
BIOTECH: Firm Organizes Workspace To Foster Collaboration
The key growth strategy for San Diego drug developer Isis Pharmaceuticals Inc. is to … not grow. At least, not grow too much.
PROPERTY: Company Puts Capital Into Home Renovations
Having flipped houses during the depths of the recession, the guys at Renovation Realty knew their best payoffs were behind them.
MEDICINE: Aim Is To Regenerate Affected Regions of the Brain
The Carlsbad-based International Stem Cell Corp. is making strides in developing a cure for Parkinson’s disease, a devastating degenerative brain disorder most common in the elderly.
BIOTECH: New Office Will Expand DSM’s Move to Biofuel
Exactly one year after it purchased $37 million worth of food processing and oil extracting assets from San Diego-based Verenium Corp., Netherlands-based Royal DSM N.V. has christened a new outpost in Sorrento Valley.
Bristol-Myers Squibb is pulling the plug on La Jolla-based diabetes drug manufacturer Amylin Pharmaceuticals Inc., which it acquired last year in a multibillion dollar deal. Amylin, which employs 420 in San Diego, will be shuttered by late 2014.